Brings 25 years of global operations and supply chain experience to Piramal
Piramal Pharma Limited's Pharma Solutions business, a leading Contract Development and Manufacturing Organization (CDMO), today announced the appointment of Herve Berdou as Chief Operating Officer, Piramal Pharma Solutions (PPS).
Berdou joins Piramal Pharma Solutions from Lonza, where he was the Global Head of Operations, Cell and Gene Technologies. He has more than two decades of experience across global supply chain, procurement, and operations, including manufacturing and site head positions at both small and large facilities.
At Lonza, Berdou led a network of contract services sites across the globe. Prior to that, he worked with a number of well-respected pharmaceutical companies, including AstraZeneca & MedImmune and Novartis.
With a legacy of experience in both the CDMO and pharma innovator/generic sides of drug development and manufacturing, he brings an understanding of both perspectives to PPS.
Peter DeYoung, Chief Executive Officer, Piramal Pharma Solutions, said, "I welcome Herve to PPS and wish him all the success in the new role. His broad, in-depth industry and functional expertise will help us create value for all our stakeholders as we continue our journey of profitable growth. His blend of CDMO and innovative pharmaceutical company experience positions him to understand and meet the needs of our customers and their patients. His multi-country operating track record will bring the best of our team and site network to our clients as we deliver integrated projects and support their clinical progression and commercial success. Herve's management style is aligned to our values and our cultural priorities."
Berdou holds a Master's (DESS) in Procurement and Supply Chain from IAE in Grenoble, France - Écoles Universitaires de Management, and a degree in Economics and Politics from Université Pierre Mendès-France.
Subscribe To Our Newsletter & Stay Updated